Radiopharm Theranostics Ltd
RADXNasdaq
$4.43
↑ +3.3%Jul 17 close · end-of-day
Price
1Y↓ -0.4%
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
Key statistics
No screener snapshot for this ticker.
Company profile
Radiopharm Theranostics Limited a clinical-stage radiotherapeutics company, engages in the research and development of radiopharmaceutical products for diagnostic and therapeutic uses in areas with high unmet medical needs. The company was incorporated in 2021 and is based in Carlton, Australia.
- CEO
- Riccardo Canevari
- Sector
- Manufacturing
- Industry
- Pharmaceutical Products
- Employees
- 14
- Website
- radiopharmtheranostics.com
Earnings
No reported earnings periods on file.
Financial statements
No annual data.
No quarterly data.
Company news
Apr 29, 2026
Apr 28, 2026
Apr 23, 2026
Analyst estimates
Coming soonConsensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
Insider transactions
No insider transactions in the last 12 months.
No insider transactions on file.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.